It is particularly useful in patient groups where there is limited time available for assessment, such as the very ill or elderly or when repeated measures are taken on a frequent basis (Broadbent et al 2006). Cross-cultural adaptation of this questionnaire has been completed in Dutch and Spanish (Raaij et al 2012, Pacheco-Heurgo et al 2012). Although the original English version of Brief IPQ has been shown to have good reliability and validity, the content validity (such as misinterpretation of some items) of the Dutch version of the questionnaire has been questioned when participants reported difficulties (van Oort et EPZ6438 al 2011). The validity
of adaptations of the questionnaire
in other languages must be tested before using the adapted questionnaire. this website “
“Latest update: 2012. Next update: Not indicated. Patient group: Adults with symptomatic hand, hip, or knee osteoarthritis (OA). Intended audience: Health care providers involved in the management of patients with OA. Additional versions: Supplementary material, including details of the publications and evidence for the reviewed interventions, is available to be downloaded: http://onlinelibrary.wiley.com/doi/10.1002/acr.21596/suppinfo. Expert working group: A technical expert panel of 13 experts from the USA and Canada was convened. It included academic and practising rheumatologists, primary care physicians, physiatrists, geriatricians, orthopaedic surgeons, and occupational and physical therapists. Funded by: The American College of Rheumatology. Consultation with: The American College of Rheumatology board of directors. Approved by: The American College of Rheumatology. Location: The guidelines are published as: Hochberg MC et al (2012). American College of Rheumatology 2012 recommendations for the Dichloromethane dehalogenase use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee. Arthritis Care & Research 64: 465–474. They are also available at: http://www.rheumatology.org/practice/clinical/guidelines/PDFs/ACR_OA_Guidelines_FINAL.pdf.
Description: These guidelines present evidence for the management of patients with symptomatic hand, hip, or knee OA using pharmacologic or nonpharmacologic therapies. The expert panel considered both direct evidence from the research literature in addition to over 10 other clinical practice guidelines, white papers, or scientific statements in the construction of the guidelines. The guidelines use three base cases, one each for hand, hip, and knee OA, to outline and discuss the evidence available for the management of these conditions. Recommendations are summarised in six tables, with a separate table for pharmacologic and nonpharmacologic therapies for the three conditions.